Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/14/2025

Insulin Pump Therapy for Type 1 Diabetes

Primary Indications for Transitioning to Pump Therapy

  • The American Diabetes Association recommends considering insulin pump therapy for patients with type 1 diabetes who have inadequate glycemic control, defined as an A1C of 7% or higher, despite optimized multiple daily injections with appropriate basal-bolus dosing 1
  • The American Diabetes Association suggests that insulin pump therapy may be beneficial for patients who experience frequent or severe hypoglycemic episodes, especially nocturnal hypoglycemia, or have pronounced dawn phenomenon 1
  • The British Journal of Anaesthesia notes that patient preference is a significant factor in considering insulin pump therapy, particularly for highly motivated patients who desire greater flexibility and are willing to engage in intensive diabetes self-management 2, 3

Clinical Advantages of Pump Therapy Over MDI

  • A meta-analysis published in Diabetes Care found that insulin pump therapy results in a modest A1C improvement of 0.30% (95% CI -0.58 to -0.02) compared to multiple daily injections 1
  • The British Journal of Anaesthesia highlights the precise basal delivery and enhanced bolus accuracy of insulin pumps, allowing for quantitative administration and instantaneous changes in insulin delivery 3

Patient Selection Criteria

  • The American Diabetes Association recommends that patients who are considered for insulin pump therapy should demonstrate high motivation and education level, as well as proficiency in carbohydrate counting and correction dose calculations 1, 2, 3
  • The British Journal of Anaesthesia emphasizes the importance of frequent glucose monitoring and technical aptitude in managing insulin pump therapy 2, 3

Critical Safety Considerations

  • The Praxis Medical Insights guidelines note that patients and providers must understand the risk of rapid insulin deficiency and diabetic ketoacidosis associated with insulin pump therapy, particularly in cases of disconnection, occlusion, or pump malfunction 4
  • The British Journal of Anaesthesia highlights the importance of hospital protocols for inpatient pump management and education for healthcare professionals 2, 3

Referral Pathway for Remote Communities

  • The British Journal of Anaesthesia suggests that general medicine internists with diabetes training in remote communities can initiate pump therapy locally if they have completed specialized pump training and have access to pump company support for technical issues 2, 3
  • The Praxis Medical Insights guidelines recommend establishing a telemedicine connection with an endocrinology center for complex cases and ongoing consultation 2, 3